LXEO Acquisition: a positive outcome, +8.9%

On September 29, 2026, Lexeo Therapeutics, Inc. reached its Acquisition. The result was a positive outcome, and the stock moved +8.9% in the window around the event. It had already run -31.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.